Peptide Promises Unraveled The recent FDA advisory panel vote on certain peptides has sent shockwaves through the supplement industry, sparking debate about what this means for consumers and regulators.
On one hand, the decision validates these compounds' efficacy; on the other, it raises questions about an unregulated market's unchecked growth.
The peptide boom, fueled by social media hype and anecdotal evidence, has led to a proliferation of products claiming improved muscle recovery and enhanced cognitive function.